| Cipla Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.44 | 3.54 | 3.60 | 3.25 | 2.88 |
| Fixed Assets | 2.28 | 2.10 | 1.89 | 1.81 | 1.64 |
| Inventory | 5.55 | 5.08 | 4.43 | 4.17 | 3.70 |
| Debtors | 5.82 | 5.95 | 5.94 | 5.26 | 3.43 |
| Interest Cover Ratio | 429.12 | 263.22 | 152.55 | 142.66 | 61.64 |
| PBIDTM (%) | 37.06 | 35.71 | 27.84 | 32.86 | 28.72 |
| PBITM (%) | 34.05 | 32.16 | 23.68 | 29.34 | 24.58 |
| PBDTM (%) | 36.98 | 35.58 | 27.68 | 32.65 | 28.32 |
| CPM (%) | 30.09 | 28.14 | 21.68 | 26.11 | 25.64 |
| APATM (%) | 27.08 | 24.60 | 17.52 | 22.59 | 21.49 |
| ROCE (%) | 21.40 | 20.10 | 14.29 | 17.93 | 14.67 |
| RONW (%) | 17.17 | 15.50 | 10.66 | 13.94 | 13.01 |